Cellectis SA

France
Cellectis SA

Cellectis is a biopharmaceutical company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART). The company’s mission is to develop a new generation of cancer therapies based on engineered T-cells.Using its life-science-focused, pioneering genome-engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets.

Private/Public:public
Phone:+33 (0)1 81 69 16 00
Fax:+33 (0)1 81 69 16 08
Email:[email protected]
Website:http://www.cellectis.com/en/
Address:Biopark, 8 rue de la Croix de Jarry, 75013 Paris, France

1999
Since
1
Country
4
Top Service Categories
11
Sub-Service Categories

Development Stages

For Services/Products


Therapeutic Categories

Main Disease Areas


Facility TypeAddressTelephoneCityFaxCountryState CodeService CategoriesFacility SizeYear BuiltNumber Of EmployeesNote
Regional/Country Headquarters430 East 29th Street New York, NY 10016+1 (347) 752-4044New YorkUnited States of AmericaNY-New York
Regional/Country Headquarters2500 Sumner Boulevard Raleigh, NC 27616+1 (984) 477-9025 RaleighUnited States of AmericaNC-North Carolina
Global Corporate HeadquartersBiopark, 8 rue de la Croix de Jarry, 75013 Paris+33 (0)1 81 69 16 00ParisFrance

See all company news

Analytical Equipment

Manufacturing Equipment

Facility Inspection/License Status